Wei Fan1, Zhongying Huang1, Zhun Xiao1, Shangwei Li1, Qianhong Ma2. 1. Center of Reproductive Medicine, The West China Second University Hospital, Sichuan University, Sichuan, People's Republic of China. 2. Center of Reproductive Medicine, The West China Second University Hospital, Sichuan University, Sichuan, People's Republic of China. qianhong_ma@163.com.
Abstract
PURPOSE: Cytochrome P450 1A1 (CYP1A1) polymorphisms were implicated in endometriosis risk, but individual published studies showed inconclusive results. Thus, a meta-analysis was performed to clarify the effect of CYP1A1 polymorphisms on endometriosis risk. METHODS: PubMed, Embase, and CNKI databases were searched to identify the eligible studies focusing on the associations between CYP1A1 MspI and Ile462Val polymorphisms and susceptibility to endometriosis. Summary odds ratios (ORs) and 95 % confidence intervals (95 % CIs) for CYP1A1 polymorphisms and endometriosis were calculated. RESULTS: Pooled analysis of 12 studies involved a total of 1555 cases and 2868 controls showed that in all genetic models, no significant association between CYP1A1 MspI polymorphism and endometriosis risk was observed in the overall, Asians and Caucasians population, respectively. Interestingly, increased endometriosis risk was associated with carrying the C allele of CYP1A1 combined with GSTM1 null genotypes. For CYP1A1 Ile462Val polymorphism, eight studies were available (878 cases and 1991 controls). In the overall analysis, CYP1A1 Ile462Val polymorphism had a statistically significant association with increased endometriosis risk in allele contrast and all genetic models except the model of Val/Ile vs. Ile/Ile. In the subgroup analysis by ethnicity, significant elevated endometriosis risk was associated with CYP1A1 Ile462Val polymorphism in Asians but not in Caucasians under all genetic models. No publication bias was found in the present studies. CONCLUSIONS: This meta-analysis suggested that CYP1A1 Ile462Val polymorphism was associated with an increased risk of endometriosis, particularly in Asians. CYP1A1 MspI polymorphism may not be associated with endometriosis risk, but GSTM1 and CYP1A1 MspI polymorphism may have a joint effect on endometriosis risk.
PURPOSE:Cytochrome P450 1A1 (CYP1A1) polymorphisms were implicated in endometriosis risk, but individual published studies showed inconclusive results. Thus, a meta-analysis was performed to clarify the effect of CYP1A1 polymorphisms on endometriosis risk. METHODS: PubMed, Embase, and CNKI databases were searched to identify the eligible studies focusing on the associations between CYP1A1 MspI and Ile462Val polymorphisms and susceptibility to endometriosis. Summary odds ratios (ORs) and 95 % confidence intervals (95 % CIs) for CYP1A1 polymorphisms and endometriosis were calculated. RESULTS: Pooled analysis of 12 studies involved a total of 1555 cases and 2868 controls showed that in all genetic models, no significant association between CYP1A1 MspI polymorphism and endometriosis risk was observed in the overall, Asians and Caucasians population, respectively. Interestingly, increased endometriosis risk was associated with carrying the C allele of CYP1A1 combined with GSTM1 null genotypes. For CYP1A1Ile462Val polymorphism, eight studies were available (878 cases and 1991 controls). In the overall analysis, CYP1A1Ile462Val polymorphism had a statistically significant association with increased endometriosis risk in allele contrast and all genetic models except the model of Val/Ile vs. Ile/Ile. In the subgroup analysis by ethnicity, significant elevated endometriosis risk was associated with CYP1A1Ile462Val polymorphism in Asians but not in Caucasians under all genetic models. No publication bias was found in the present studies. CONCLUSIONS: This meta-analysis suggested that CYP1A1Ile462Val polymorphism was associated with an increased risk of endometriosis, particularly in Asians. CYP1A1 MspI polymorphism may not be associated with endometriosis risk, but GSTM1 and CYP1A1 MspI polymorphism may have a joint effect on endometriosis risk.
Authors: Demetrios A Arvanitis; Georgios E Koumantakis; Anastasia G Goumenou; Ioannis M Matalliotakis; Eugenios E Koumantakis; Demetrios A Spandidos Journal: Fertil Steril Date: 2003-03 Impact factor: 7.329
Authors: Ambros Huber; Christoph C Keck; Lukas A Hefler; Christian Schneeberger; Johannes C Huber; Eva-Katrin Bentz; Clemens B Tempfer Journal: Obstet Gynecol Date: 2005-11 Impact factor: 7.661
Authors: D C Spink; H P Eugster; D W Lincoln; J D Schuetz; E G Schuetz; J A Johnson; L S Kaminsky; J F Gierthy Journal: Arch Biochem Biophys Date: 1992-03 Impact factor: 4.013